Literature DB >> 11404385

A chimeric MIP-1alpha/RANTES protein demonstrates the use of different regions of the RANTES protein to bind and activate its receptors.

C Blanpain1, R Buser, C A Power, M Edgerton, C Buchanan, M Mack, G Simmons, P R Clapham, M Parmentier, A E Proudfoot.   

Abstract

Human RANTES (CCL5) and MIP-1alpha (CCL3) bind and activate several CC chemokine receptors. RANTES is a high-affinity ligand for CCR1 and CCR5, and it binds CCR3 with moderate affinity and CCR4 with low affinity. MIP-1alpha has similar binding characteristics to RANTES except that it does not bind to CCR3. Here we have generated a chimera of human MIP-1alpha and RANTES, called MIP/RANTES, consisting of the eight amino terminal residues of MIP-1alpha preceding the CC motif, and the remainder of the sequence is RANTES. The chimera is able to induce chemotaxis of human monocytes. MIP/RANTES has >100-fold reduction in binding to CCR1 and does not bind to CCR3 but retains full, functional binding to CCR5. It has equivalent affinity for CCR5 to MIP-1alpha and RANTES, binding with an IC(50) of 1.12 nM, and is able to mobilize calcium and induce endocytosis of CCR5 in PBMC in a manner equi-potent to RANTES. It also retains the ability to inhibit R5 using HIV-1 strains. Therefore, we conclude that the amino terminus of RANTES is not involved in CCR5 binding, but it is essential for CCR1 and CCR3.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11404385

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  15 in total

1.  Allosteric and orthosteric sites in CC chemokine receptor (CCR5), a chimeric receptor approach.

Authors:  Stefanie Thiele; Anne Steen; Pia C Jensen; Jacek Mokrosinski; Thomas M Frimurer; Mette M Rosenkilde
Journal:  J Biol Chem       Date:  2011-08-30       Impact factor: 5.157

2.  Invariant natural killer T cells in children with eosinophilic esophagitis.

Authors:  S Jyonouchi; C L Smith; F Saretta; V Abraham; K R Ruymann; P Modayur-Chandramouleeswaran; M-L Wang; J M Spergel; A Cianferoni
Journal:  Clin Exp Allergy       Date:  2014-01       Impact factor: 5.018

3.  Identification of Functionally Distinct Mx1+αSMA+ Periosteal Skeletal Stem Cells.

Authors:  Laura C Ortinau; Hamilton Wang; Kevin Lei; Lorenzo Deveza; Youngjae Jeong; Yannis Hara; Ingo Grafe; Scott B Rosenfeld; Dongjun Lee; Brendan Lee; David T Scadden; Dongsu Park
Journal:  Cell Stem Cell       Date:  2019-12-05       Impact factor: 24.633

4.  Chemokine CCL5 promotes robust optic nerve regeneration and mediates many of the effects of CNTF gene therapy.

Authors:  Lili Xie; Yuqin Yin; Larry Benowitz
Journal:  Proc Natl Acad Sci U S A       Date:  2021-03-02       Impact factor: 11.205

5.  CD8 chemokine receptors in chronic obstructive pulmonary disease.

Authors:  L J C Smyth; C Starkey; F S Gordon; J Vestbo; D Singh
Journal:  Clin Exp Immunol       Date:  2008-08-22       Impact factor: 4.330

6.  Chemokine Ligand 5 (CCL5) and chemokine receptor (CCR5) genetic variants and prostate cancer risk among men of African Descent: a case-control study.

Authors:  Lacreis R Kidd; Dominique Z Jones; Erica N Rogers; Nayla C Kidd; Sydney Beache; James E Rudd; Camille Ragin; Maria Jackson; Norma McFarlane-Anderson; Marshall Tulloch-Reid; Seian Morrison; Guy N Brock; Shirish S Barve; Kevin S Kimbro
Journal:  Hered Cancer Clin Pract       Date:  2012-11-20       Impact factor: 2.857

7.  Ligand up-regulation does not correlate with a role for CCR1 in pathogenesis in a mouse model of non-lymphocyte-mediated neurological disease.

Authors:  Meryll E Corbin; Susan Pourciau; Timothy W Morgan; Marc Boudreaux; Karin E Peterson
Journal:  J Neurovirol       Date:  2006-08       Impact factor: 3.739

8.  The cholesterol-binding antibiotic nystatin induces expression of macrophage inflammatory protein-1 in macrophages.

Authors:  Seungil Baek; Sun-Mi Kim; Sae-A Lee; Byung-Yong Rhim; Seong-Kug Eo; Koanhoi Kim
Journal:  Biomol Ther (Seoul)       Date:  2013-01       Impact factor: 4.634

9.  Oligomerized, filamentous surface presentation of RANTES/CCL5 on vascular endothelial cells.

Authors:  Inger Øynebråten; Nicolas Barois; Trygve Bergeland; Axel M Küchler; Oddmund Bakke; Guttorm Haraldsen
Journal:  Sci Rep       Date:  2015-03-20       Impact factor: 4.379

10.  Structural basis of chemokine sequestration by a tick chemokine binding protein: the crystal structure of the complex between Evasin-1 and CCL3.

Authors:  João M Dias; Christophe Losberger; Maud Déruaz; Christine A Power; Amanda E I Proudfoot; Jeffrey P Shaw
Journal:  PLoS One       Date:  2009-12-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.